Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
S422599-1ml | 1ml | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $69.90 |
Antioxidant agent
Synonyms | S-allyl-L-cysteine | 21593-77-1 | S-Allylcysteine | (R)-3-(Allylthio)-2-aminopropanoic acid | L-DEOXYALLIIN | S-Allyl cysteine | L-Cysteine, S-2-propenyl- | allyl-cysteine | DEOXYALLIIN | S-prop-2-en-1-yl-L-cysteine | S-2-propenyl-L-cysteine | CHEBI:74077 | S-allyl-laevo-cystein |
---|---|
Specifications & Purity | 10mM in Water |
Biochemical and Physiological Mechanisms | Antioxidant agent. Inhibits reperfusion-induced HIF-1α, VEGF, and MMP-9 upregulation. Shows selective neuroprotective effects against amyloid β-protein-induced cell death. Shows anti-ischemic effects in vivo. Orally active. |
Storage Temp | Store at -80°C |
Shipped In | Ice chest + Ice pads |
Product Description | L-Deoxyalliin is a water-soluble organosulfur obtained from garlic. L-Deoxyalliin is a proven candidate for chemoprevention in a clinical trial. |
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | (2R)-2-amino-3-prop-2-enylsulfanylpropanoic acid |
---|---|
INCHI | InChI=1S/C6H11NO2S/c1-2-3-10-4-5(7)6(8)9/h2,5H,1,3-4,7H2,(H,8,9)/t5-/m0/s1 |
InChi Key | ZFAHNWWNDFHPOH-YFKPBYRVSA-N |
Canonical SMILES | C=CCSCC(C(=O)O)N |
Isomeric SMILES | C=CCSC[C@@H](C(=O)O)N |
WGK Germany | 3 |
RTECS | HA2466200 |
PubChem CID | 9793905 |
Molecular Weight | 161.22 |
Reaxy-Rn | 1722895 |
Enter Lot Number to search for COA:
Sensitivity | Air sensitive |
---|---|
Specific Rotation[α] | -15° (C=1,H2O) |
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H317:May cause an allergic skin reaction |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P501:Dispose of contents/container to ... P272:Contaminated work clothing should not be allowed out of the workplace. P333+P313:IF SKIN irritation or rash occurs: Get medical advice/attention. P362+P364:Take off contaminated clothing and wash it before reuse. |
WGK Germany | 3 |
RTECS | HA2466200 |
Reaxy-Rn | 1722895 |
1. Miaomiao Liu, Siqi Jing, Tiantian Xie, Haiyan Liu, Ligai Bai. (2024) Fabrication of a bio-based polymer adsorbent and its application for extraction and determination of glycosides from Huangqi Liuyi decoction. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 240 (115947). [PMID:38181557] [10.1016/j.jpba.2023.115947] |
2. Jing Nie, Rui Weng, Chunlin Li, Xiuhua Liu, Fang Wang, Karyne M. Rogers, Yongzhong Qian, Yongzhi Zhang, Yuwei Yuan. (2022) Chemometric origin classification of Chinese garlic using sulfur-containing compounds, assisted by stable isotopes and bioelements. FOOD CHEMISTRY, 394 (133557). [PMID:35759834] [10.1016/j.foodchem.2022.133557] |
3. Rong Xu, Siyan Qiu, Jie Zhang, Xiaoli Liu, Ling Zhang, Haizhu Xing, Min You, Man Wang, Yuting Lu, Peng Zhang, Jing Zhu. (2022) Silibinin Schiff Base Derivatives Counteract CCl4-Induced Acute Liver Injury by Enhancing Anti-Inflammatory and Antiapoptotic Bioactivities. Drug Design Development and Therapy, 16 (1441-1456). [PMID:35601675] [10.2147/DDDT.S356847] |
4. Qiang Chen, Chunjing Guo, Xiudi Zhou, Yanguo Su, Huimin Guo, Min Cao, Jing Li, Yue Zhang, Weiyi Zhao, Xin Gao, Shuqi Mi, Daquan Chen. (2022) N-acetylneuraminic acid and chondroitin sulfate modified nanomicelles with ROS-sensitive H2S donor via targeting E-selectin receptor and CD44 receptor for the efficient therapy of atherosclerosis. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 211 (259). [PMID:35513096] [10.1016/j.ijbiomac.2022.04.180] |
5. Xiaoying Zhang, Cuifeng Wang, Jiamin Wu, Yajun Liu, Zeping Yang, Ye Zhang, Xiaofeng Sui, Min Li, Min Feng. (2017) An acid-seeking carrier-free drug achieves high antitumor activity via a “solution-particle” transition. JOURNAL OF CONTROLLED RELEASE, 262 (305). [PMID:28797579] [10.1016/j.jconrel.2017.08.008] |
1. Miaomiao Liu, Siqi Jing, Tiantian Xie, Haiyan Liu, Ligai Bai. (2024) Fabrication of a bio-based polymer adsorbent and its application for extraction and determination of glycosides from Huangqi Liuyi decoction. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 240 (115947). [PMID:38181557] [10.1016/j.jpba.2023.115947] |
2. Jing Nie, Rui Weng, Chunlin Li, Xiuhua Liu, Fang Wang, Karyne M. Rogers, Yongzhong Qian, Yongzhi Zhang, Yuwei Yuan. (2022) Chemometric origin classification of Chinese garlic using sulfur-containing compounds, assisted by stable isotopes and bioelements. FOOD CHEMISTRY, 394 (133557). [PMID:35759834] [10.1016/j.foodchem.2022.133557] |
3. Rong Xu, Siyan Qiu, Jie Zhang, Xiaoli Liu, Ling Zhang, Haizhu Xing, Min You, Man Wang, Yuting Lu, Peng Zhang, Jing Zhu. (2022) Silibinin Schiff Base Derivatives Counteract CCl4-Induced Acute Liver Injury by Enhancing Anti-Inflammatory and Antiapoptotic Bioactivities. Drug Design Development and Therapy, 16 (1441-1456). [PMID:35601675] [10.2147/DDDT.S356847] |
4. Qiang Chen, Chunjing Guo, Xiudi Zhou, Yanguo Su, Huimin Guo, Min Cao, Jing Li, Yue Zhang, Weiyi Zhao, Xin Gao, Shuqi Mi, Daquan Chen. (2022) N-acetylneuraminic acid and chondroitin sulfate modified nanomicelles with ROS-sensitive H2S donor via targeting E-selectin receptor and CD44 receptor for the efficient therapy of atherosclerosis. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 211 (259). [PMID:35513096] [10.1016/j.ijbiomac.2022.04.180] |
5. Xiaoying Zhang, Cuifeng Wang, Jiamin Wu, Yajun Liu, Zeping Yang, Ye Zhang, Xiaofeng Sui, Min Li, Min Feng. (2017) An acid-seeking carrier-free drug achieves high antitumor activity via a “solution-particle” transition. JOURNAL OF CONTROLLED RELEASE, 262 (305). [PMID:28797579] [10.1016/j.jconrel.2017.08.008] |